Evan Wang's questions to Moderna Inc (MRNA) leadership • Q3 2024
Question
Evan Wang asked about potential policy barriers to vaccine use under a new U.S. administration and the company's confidence in its ex-U.S. RSV vaccine competitiveness, given competitor commentary on data sufficiency.
Answer
CEO Stéphane Bancel stated that Moderna has always worked collaboratively with government leaders and will continue to do so, as its mission to improve public health aligns with any administration's goals. Regarding ex-U.S. RSV, he noted that the ramp-up is slower due to varied approval, recommendation, and pricing negotiation timelines in international markets.